Chae Y H, Ji B Y, Lin J M, Fu P P, Cho B P, El-Bayoumy K
Division of Cancer Etiology and Prevention, American Health Foundation, Valhalla, New York 10595, USA.
Chem Res Toxicol. 1999 Feb;12(2):180-6. doi: 10.1021/tx9802318.
We determined whether DNA adducts derived from 4-nitropyrene (4-NP) are formed via nitroreduction or ring oxidation. DNA adduct markers derived from both pathways were prepared and, consequently, were compared with those obtained in vivo in rats treated with 4-NP. Following in vitro reaction of 9,10-epoxy-9,10-dihydro-4-nitropyrene (4-NP-9,10-epoxide), an intermediate metabolite derived from ring oxidation of 4-NP, with calf thymus DNA (average level of binding in two determinations was 8.5 nmol/mg of DNA), DNA was enzymatically hydrolyzed to deoxyribonucleosides and the DNA hydrolysates were analyzed by HPLC. Electrospray mass and 1H NMR spectra of the major products indicated that these adducts are deoxyguanosine (dG) derivatives that resulted from N2-dG substitution at the 9- or 10-position of the pyrene nucleus. However, these adducts were not detected in vivo in the rat mammary gland and liver following the administration of 4-NP. Nitroreduction of 4-NP catalyzed by xanthine oxidase in the presence of DNA resulted in three major putative DNA adducts (level of binding of 12.0 +/- 1.1 nmol/mg of DNA, n = 4) designated as peak 1 (46%), peak 2 (25%), and peak 3 (17%). Although peak 1 was further resolved into peaks 1a and 1b, both were unstable and gradually decomposed to peak 2, and the latter was unequivocally identified as pyrene-4,5-dione. On the basis of electrospray mass spectral analysis, peak 3 was tentatively identified as a deoxyinosine-derived 4-aminopyrene adduct. None of the adducts derived from nitroreduction of 4-NP catalyzed by xanthine oxidase coeluted with the synthetic standard N-(deoxyguanosin-8-yl)-4-aminopyrene prepared by reacting dG with N-acetoxy-4-aminopyrene. Nevertheless, HPLC analysis of the hydrolysates of liver and mammary DNA obtained from rats treated with [3H]-4-NP yielded four radioactive peaks, all of which coeluted with the markers derived from the nitroreduction pathway. These results indicate that nitroreduction is primarily responsible for DNA adduct formation in the liver and, especially, in the mammary gland which is the organ susceptible to carcinogenesis by this environmental agent.
我们确定了源自4-硝基芘(4-NP)的DNA加合物是通过硝基还原还是环氧化形成的。制备了源自这两种途径的DNA加合物标记物,并将其与用4-NP处理的大鼠体内获得的加合物标记物进行比较。9,10-环氧-9,10-二氢-4-硝基芘(4-NP-9,10-环氧化物)是4-NP环氧化产生的中间代谢产物,它与小牛胸腺DNA进行体外反应(两次测定的平均结合水平为8.5 nmol/mg DNA)后,DNA经酶水解为脱氧核糖核苷,然后通过HPLC分析DNA水解产物。主要产物的电喷雾质谱和1H NMR光谱表明,这些加合物是脱氧鸟苷(dG)衍生物,是芘核9位或10位的N2-dG取代产物。然而,在给大鼠施用4-NP后,在大鼠乳腺和肝脏中未在体内检测到这些加合物。在DNA存在下,黄嘌呤氧化酶催化4-NP的硝基还原产生了三种主要的假定DNA加合物(结合水平为12.0±1.1 nmol/mg DNA,n = 4),分别命名为峰1(46%)、峰2(25%)和峰3(17%)。尽管峰1进一步分解为峰1a和峰1b,但两者都不稳定,逐渐分解为峰2,后者被明确鉴定为芘-4,5-二酮。基于电喷雾质谱分析,峰3初步鉴定为源自脱氧肌苷的4-氨基芘加合物。黄嘌呤氧化酶催化4-NP硝基还原产生的加合物中,没有一种与通过dG与N-乙酰氧基-4-氨基芘反应制备的合成标准品N-(脱氧鸟苷-8-基)-4-氨基芘共洗脱。然而,对用[3H]-4-NP处理的大鼠肝脏和乳腺DNA水解产物进行的HPLC分析产生了四个放射性峰,所有这些峰都与源自硝基还原途径的标记物共洗脱。这些结果表明,硝基还原是肝脏中DNA加合物形成的主要原因,尤其是在乳腺中,乳腺是这种环境致癌物易感的器官。